EXPO
Exponent, Inc. NASDAQ$65.94
Mkt Cap $3.2B
52w Low $63.25
14.4% of range
52w High $81.95
50d MA $67.83
200d MA $70.19
P/E (TTM)
31.4x
EV/EBITDA
21.8x
P/B
8.5x
Debt/Equity
0.2x
ROE
27.2%
P/FCF
29.2x
RSI (14)
—
ATR (14)
—
Beta
0.80
50d MA
$67.83
200d MA
$70.19
Avg Volume
515.1K
About
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction con…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.56 | 0.59 | +5.4% | 66.89 | +0.5% | -2.4% | -2.9% | -2.7% | — | — | — |
| Feb 5, 2026 | AMC | 0.47 | 0.49 | +4.3% | 70.83 | +2.6% | +12.7% | +10.6% | +7.5% | +1.3% | -5.2% | — |
| Oct 30, 2025 | AMC | 0.50 | 0.55 | +10.0% | 66.82 | +1.3% | +6.0% | +7.9% | +7.3% | +10.2% | +6.6% | — |
| Jul 31, 2025 | AMC | 0.48 | 0.52 | +8.3% | 68.96 | -1.6% | -0.9% | +2.3% | +3.3% | +3.7% | +3.3% | — |
| May 1, 2025 | AMC | 0.48 | 0.52 | +8.3% | 77.82 | -4.9% | -1.3% | -3.1% | -3.4% | -3.8% | -0.8% | — |
| Feb 6, 2025 | AMC | 0.40 | 0.46 | +15.0% | 89.82 | +5.8% | +1.2% | +1.2% | +1.3% | +0.8% | +0.7% | — |
| Oct 24, 2024 | AMC | 0.48 | 0.50 | +4.2% | 106.36 | +1.1% | -8.9% | -8.0% | -8.1% | -9.5% | -11.3% | — |
| Jul 25, 2024 | AMC | 0.50 | 0.57 | +14.0% | 106.07 | +1.8% | -0.6% | -0.9% | +0.8% | +0.0% | -1.4% | — |
| Apr 25, 2024 | AMC | 0.47 | 0.59 | +25.5% | 79.68 | +19.2% | +19.5% | +17.0% | +15.3% | +15.3% | +16.0% | — |
| Feb 1, 2024 | AMC | 0.44 | 0.41 | -6.8% | 89.93 | -19.6% | -12.8% | -13.5% | -12.9% | -14.4% | -12.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | UBS | Maintains | Neutral → Neutral | — | $66.89 | $67.20 | +0.5% | -2.4% | — | — | — | — |
| Mar 26 | JP Morgan | Maintains | Overweight → Overweight | — | $65.34 | $65.13 | -0.3% | -0.1% | -1.3% | -0.2% | -0.1% | -0.5% |
| Dec 15 | UBS | Maintains | Neutral → Neutral | — | $73.63 | $74.62 | +1.3% | +1.4% | +0.8% | +0.1% | -0.5% | -2.2% |
| Nov 17 | William Blair | Upgrade | Market Perform → Outperform | — | $69.94 | $70.20 | +0.4% | -1.5% | -1.7% | -2.5% | -2.0% | +1.0% |
| Jul 26 | Truist | Maintains | Buy → Buy | — | $106.07 | $108.00 | +1.8% | -0.6% | -0.9% | +0.8% | +0.0% | -1.4% |
| Apr 29 | Truist | Maintains | Buy → Buy | — | $95.21 | $95.06 | -0.2% | -2.1% | -3.5% | -3.5% | -2.9% | -0.9% |
| Feb 2 | Truist | Maintains | Buy → Buy | — | $89.93 | $72.26 | -19.6% | -12.8% | -13.5% | -12.9% | -14.4% | -12.6% |
| Jul 31 | Truist | Maintains | Buy → Buy | — | $89.07 | $89.16 | +0.1% | +0.6% | -0.9% | +0.4% | -0.3% | -1.0% |
| Jun 1 | UBS | Maintains | Neutral → Neutral | — | $91.32 | $90.73 | -0.6% | +0.8% | +3.4% | +2.2% | +4.5% | +5.8% |
| Apr 5 | Truist | Maintains | Buy → Buy | — | $105.58 | $106.50 | +0.9% | +1.4% | +2.0% | +2.0% | +1.2% | -0.2% |
Recent Filings
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
EXPO's CFO transition to Eric Anderson may signal strategic changes in financial direction; investors should assess Anderson's track record and whether this indicates upcoming capital allocation or operational shifts.
Apr 6
8-K · 7.01
! Medium
Exponent Inc -- 8-K 7.01: Regulation FD Disclosure
Exponent's board declared a quarterly dividend of $0.31 per share payable March 20, 2026, signaling confidence in cash generation and providing shareholders with regular income distributions.
Feb 5
Data updated apr 25, 2026 8:15am
· Source: massive.com